Long-term safety of ixekizumab

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2024年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e202 / e202
页数：1
相关论文
共 50 条
  • [1] Long-term safety of ixekizumab confirmed in PsA
    Clarke J.
    Nature Reviews Rheumatology, 2020, 16 (3) : 126 - 126
  • [2] Long-Term Safety Profile of Ixekizumab Treatment in Patients with Axial Spondyloarthritis
    Schwartzman, Sergio
    Sandoval, David
    Kronbergs, Andris
    Lisse, Jeffrey
    Patel, Himanshu
    Xu, Wen
    Liu-Leage, Soyi
    Magrey, Marina
    Marzo-Ortega, Helena
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Long-term Safety of Ixekizumab in Adult Patients With Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 39 - 40
  • [4] LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 37 - 37
  • [5] Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkamper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2071 - 2074
  • [6] LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    Bullock, Craig
    RHEUMATOLOGY, 2023, 62
  • [7] Long-term clinical efficacy and safety of ixekizumab for psoriatic patients: a single-center experience
    Burlando, M.
    Salvi, I.
    Castelli, R.
    Herzum, A.
    Cozzani, E.
    Parodi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (09) : 4060 - 4064
  • [8] Long-term management of pediatric psoriasis with ixekizumab: a case report
    Orsini, Diego
    Ibba, Luciano
    Narcisi, Alessandra
    Frascione, Pasquale
    Pacifico, Alessia
    Valenti, Mario
    Costanzo, Antonio
    Gargiulo, Luigi
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [9] Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
    Timothy Fitzgerald
    Maryia Zhdanava
    Dominic Pilon
    Aditi Shah
    Annalise Hilts
    Patrick Lefebvre
    Steven R. Feldman
    Dermatology and Therapy, 2023, 13 : 1053 - 1068
  • [10] Long-term efficacy of ixekizumab in erythrodermic and generalized pustular psoriasis patients
    Egawa, G.
    Honda, T.
    Kabashima, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 259 - 259
12345